In order to observe the nutrition state in the severe multiple trauma patients undergoing adjuvant recombinant human growth hormone (rhGH) nutritional support therapy, 45 patients with severe multiple traumas (ISS>...In order to observe the nutrition state in the severe multiple trauma patients undergoing adjuvant recombinant human growth hormone (rhGH) nutritional support therapy, 45 patients with severe multiple traumas (ISS>25) were randomly divided into 3 groups. All the 3 groups had been supplied with nitrogen and caloricity according to the need of patients for 16 days. The rhGH therapy started 48 h after surgery and lasted for 14 days in two rhGH-treated groups in which rhGH was 0.2 and 0.4 U/(kg·d) respectively, and the resting group served as control one. The levels of nitrogen balance, prealbumin and safety variables (blood sugar, Na+, TT3 and TT4) were observed and com- pared among the three groups. The levels of nitrogen balance on the postoperative day (POD) 3 and 5 in the rhGH-treated groups were -1.28±3.19, 5.45±2.00 and -0.18±2.55, 6.11±1.60, respectively, which were significantly higher than those in the control group (-5.17±1.68 and -1.08±3.31, P<0.01). The values of prealbumin on the POD 3 and 5 in the rhGH-treated groups were 180.19±27.15, 194.44±50.82 and 194.94±29.65, 194.11±16.17, respectively, which were significantly higher than those in the control group (117.42±19.10 and 135.63±28.31, P<0.01). There was no sig- nificant difference between the rhGH 0.2 U/(kg·d) group and rhGH 0.4 U/(kg·d) group in both of the levels of nitrogen balance and prealbumin. It is concluded that the nutritional support therapy with adjuvant rhGH which starts 48 h after surgery improves the nutrition state of the patients with severe multiple trauma. It is safe for severe multiple trauma patients who accept rhGH at the dose of 0.2 and 0.4 U/(kg·d).展开更多
目的观察小容量高渗晶体等渗胶体混合溶液对创伤失血性休克患者的早期容量复苏效果。方法将我科收治的48例早期轻、中度创伤失血性休克患者,随机分为两组,每组24例。通过外周血管在15~20 min 内快速输注250ml 研究药物(贺苏,7.2%氯化钠...目的观察小容量高渗晶体等渗胶体混合溶液对创伤失血性休克患者的早期容量复苏效果。方法将我科收治的48例早期轻、中度创伤失血性休克患者,随机分为两组,每组24例。通过外周血管在15~20 min 内快速输注250ml 研究药物(贺苏,7.2%氯化钠/6%羟乙基淀粉200/0.5注射液)或对照药物(贺斯,0.9%氯化钠/1%羟乙基淀粉200/0.5溶液)。在给药前、给药后0.5、10、15、20、25、30 min 测定患者的血压、脉搏和休克指数;在研究开始前和给药后30 min 各采集1次外周血样本,并检测血常规、血 Na^+、Cl^-和凝血常规。结果研究组收缩压在给药后0、5、10、15、20、25、30 min 均显著高于对照组(P<0.01),舒张压在给药后0、5、10、15 min 内均显著高于对照组(P<0.05),休克指数在给药后均显著低于对照组(P<0.05)。研究组在给药后血 Na^+、Cl^-高于对照组(P<0.01),但其平均浓度在正常参考值范围内。研究组与对照组凝血功能、血常规指标差异均无统计学差异。结论小容量高渗晶体等渗胶溶液在创伤失血性休克患者早期血流动力学快速恢复作用上有良好的效果且安全性良好。展开更多
文摘In order to observe the nutrition state in the severe multiple trauma patients undergoing adjuvant recombinant human growth hormone (rhGH) nutritional support therapy, 45 patients with severe multiple traumas (ISS>25) were randomly divided into 3 groups. All the 3 groups had been supplied with nitrogen and caloricity according to the need of patients for 16 days. The rhGH therapy started 48 h after surgery and lasted for 14 days in two rhGH-treated groups in which rhGH was 0.2 and 0.4 U/(kg·d) respectively, and the resting group served as control one. The levels of nitrogen balance, prealbumin and safety variables (blood sugar, Na+, TT3 and TT4) were observed and com- pared among the three groups. The levels of nitrogen balance on the postoperative day (POD) 3 and 5 in the rhGH-treated groups were -1.28±3.19, 5.45±2.00 and -0.18±2.55, 6.11±1.60, respectively, which were significantly higher than those in the control group (-5.17±1.68 and -1.08±3.31, P<0.01). The values of prealbumin on the POD 3 and 5 in the rhGH-treated groups were 180.19±27.15, 194.44±50.82 and 194.94±29.65, 194.11±16.17, respectively, which were significantly higher than those in the control group (117.42±19.10 and 135.63±28.31, P<0.01). There was no sig- nificant difference between the rhGH 0.2 U/(kg·d) group and rhGH 0.4 U/(kg·d) group in both of the levels of nitrogen balance and prealbumin. It is concluded that the nutritional support therapy with adjuvant rhGH which starts 48 h after surgery improves the nutrition state of the patients with severe multiple trauma. It is safe for severe multiple trauma patients who accept rhGH at the dose of 0.2 and 0.4 U/(kg·d).
文摘目的观察小容量高渗晶体等渗胶体混合溶液对创伤失血性休克患者的早期容量复苏效果。方法将我科收治的48例早期轻、中度创伤失血性休克患者,随机分为两组,每组24例。通过外周血管在15~20 min 内快速输注250ml 研究药物(贺苏,7.2%氯化钠/6%羟乙基淀粉200/0.5注射液)或对照药物(贺斯,0.9%氯化钠/1%羟乙基淀粉200/0.5溶液)。在给药前、给药后0.5、10、15、20、25、30 min 测定患者的血压、脉搏和休克指数;在研究开始前和给药后30 min 各采集1次外周血样本,并检测血常规、血 Na^+、Cl^-和凝血常规。结果研究组收缩压在给药后0、5、10、15、20、25、30 min 均显著高于对照组(P<0.01),舒张压在给药后0、5、10、15 min 内均显著高于对照组(P<0.05),休克指数在给药后均显著低于对照组(P<0.05)。研究组在给药后血 Na^+、Cl^-高于对照组(P<0.01),但其平均浓度在正常参考值范围内。研究组与对照组凝血功能、血常规指标差异均无统计学差异。结论小容量高渗晶体等渗胶溶液在创伤失血性休克患者早期血流动力学快速恢复作用上有良好的效果且安全性良好。